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Background: The grand challenges approach aims to spark innovative and transformative strategies to overcome
barriers to significant global health issues. Grand Challenges Canada endorses an ‘Integrated Innovation™’ approach
that focuses on the intersection of scientific/technological, social and business innovation. In this article we explore
themes emerging from a dialogue between the authors, who are multidisciplinary recipients of the ‘Rising Stars in
Global Health’ award from Grand Challenges Canada, regarding benefits of engaging in integrated innovation
research, and recommendations for how this approach may develop in the future.
Discussion: Our dialogue followed a semi-structured interview format that addressed three topics: 1) reflections on
applying an Integrated Innovation™ approach for global health; 2) thoughts on participation in the Grand Challenges
2012 meeting; and 3) authors’ visions of Grand Challenges Canada and the Grand Challenge movement towards 2020.
The dialogue was transcribed verbatim and we used thematic analysis techniques to identify, analyze and report
themes in the data. Benefits of working using the Grand Challenges approach centered on two themes: a) the potential
for scientific breakthrough and b) building interdisciplinary collaborations and a community of scholars. Challenges and
opportunities for Grand Challenges in moving forward included: a) capacity building, particularly regarding Integrated
Innovation™ and scale-up planning; b) interdisciplinary and international mentorship for new investigators; and
c) potential for future commercialization.
Conclusions: Our discussion highlighted that Integrated Innovation™ offers the opportunity to develop new theories,
methods and approaches to global health while simultaneously fostering a collaborative spirit grounded in international,
interdisciplinary collaborations. However, the arguable over-emphasis on corporatization poses a major challenge for
new investigators. We propose a more balanced way forward that can harness technology to foster mentorship across
time and space to support the development of such skills and ideas among new investigators.
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tions in order to impact grand challenges in global
health. A grand challenge in global health is defined
as “a specific critical barrier that if removed would
help to solve an important public health problem. The
intervention(s) it could lead to might be innovative
and, if successfully implemented, will have a high like-
lihood of impact and feasibility” [2]. This differs from
a description of a global health problem (e.g. HIV,
malnutrition) in that it involves an innovative and trans-
formative strategy to overcome barriers to significant
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the mathematician David Hilbert, who challenged his
community to solve 23 major problems remaining in their
field. The Bill & Melinda Gates Foundation (BMGF) re-
vived this model and applied it to global health, challen-
ging a global panel of experts to first identify grand
challenges in this arena. Twelve grand challenges in 7
broad categories of global health were initially identified
[4,5]. The BMGF has been instrumental in spurring high-
level technological innovation to tackle these grand chal-
lenges with its highly competitive grants program. Since
then, additional grand challenges have been identified to
address issues in other areas of interest and new organiza-
tions have emerged to tackle global health via this ap-
proach, including Grand Challenges Canada (GCC). GCC’s
funding approach expands beyond the focus on scientific/
technological approaches traditionally supported by BMGF,
in that they promote Integrated Innovation™ to tackle
grand challenges in global health. Integrated Innovation™ is
the “the coordinated application of scientific/technological,
social and business innovation to develop solutions to
complex challenges” [6].
Engaging multidisciplinary voices in the articulation
and tackling of grand challenges is key to addressing
ethical, social and cultural issues that may arise in global
health research [4,5]. There are a wide range of disciplines
engaged in health promotion, including immunology,
microbiology, clinical sciences, epidemiology, environmen-
tal sciences and population/behavioral sciences. Interdis-
ciplinary and international collaboration is transforming
the ‘geography of science’ by engaging multiple competen-
cies, theoretical perspectives, and therefore solutions, to
address health issues from investigators in diverse locales,
disciplines, and sectors [5,7].
While there is great promise for interdisciplinary and
innovative approaches to address global health grand
challenges, little is known about the experiences of re-
searchers engaging in such endeavors. Especially relevant
are the views of new investigators, who are integral to
addressing global health challenges [8]. Analyses of social,
ethical and cultural issues regarding grand challenges in
global health highlighted factors to consider in this area of
research. These included community and public engage-
ment strategies, cultural acceptability of approaches, and
effective collaboration [9].
In this article we examine the experiences of four new
investigators from different disciplines who each re-
ceived a GCC ‘Rising Stars in Global Health’ award in
Round 1 (2011) or Round 2 (2012). During this period a
total of 34 such grants were awarded (see http://www.
grandchallenges.ca/our-innovators/). The authors met
while attending the Grand Challenges meeting co-organized
by GCC and BMGF in December 2012, and decided to ex-
plore the concepts presented in this debate. The groupconstitutes a representative sample of the types of innova-
tions that were financed by GCC: projects are linked to
health care delivery (CL, HD), diagnostics (HD) and novel
anti-infective therapies (SRG, AF) (Table 1). Our projects
address myriad health issues across global regions: HIV pre-
vention in post-earthquake Haiti, cancer pathology in
Kenya, tuberculosis drug development, and improved
drug-delivery against cutaneous leishmaniasis (Table 1).
We found commonality in our commitment to
community-based approaches and Integrated Innovation™,
and used our heterogeneity as a platform to reflect on
our experiences addressing grand challenges in global
health. We conducted and digitally recorded a structured
dialogue in December 2012 using a semi-structured inter-
view guide to explore three topics: 1) our reflections on
applying an Integrated Innovation™ approach in global
health research; 2) perceived benefits of our participation
in the Grand Challenges 2012 meeting; and 3) our vision
for the future of GCC towards 2020. The dialogue was
transcribed verbatim and thematic analysis techniques
from grounded theory were used to identify, analyze and
report themes in the data regarding benefits of the grand
challenges approach and recommendations for GCC mov-
ing forward [10]. Critical reflexivity in part guided this dia-
logue; this approach has been used by health practitioners
and researchers to interrogate knowledge production pro-
cesses, and how these processes reproduce or challenge
power structures [11,12]. As all of our work aimed to pro-
mote health equity among marginalized populations, this
was a fitting framework.
Discussion
Our discussion, as reported in the following paragraphs,
highlighted benefits and challenges of involvement in
GCC. A recurring theme in our discussion revealed that
while Integrated Innovation™ demonstrates a strong po-
tential for global health impact, an overemphasis on
commercialization and corporatization may have the op-
posite effect. We make recommendations and revisions
to be incorporated into the Grand Challenges Canada
approach in order to maximize the potential benefit of
addressing health challenges on a global scale, particu-
larly when supporting global health research among new
investigators (Figure 1).
Benefits of working within the grand challenges
framework
Benefits of working under the Grand Challenges approach
centered on two themes: potential for scientific break-
through and promotion of interdisciplinary collaborations.
Potential for scientific breakthrough
The authors discussed the possibilities provided by this
funding opportunity that could impact health across
Table 1 Canadian Rising Stars In Global Health Round 1 and 2 projects represented in the analysis
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The authors represent a sample of 3/19 (16%) and 1/15 (7%) Round 1 and Round 2 funded grants, respectively. Projects range in priority area, platform and
implementation regions.
*Indicates proposed implementation region.
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geared at supporting new investigators embarking on
innovative proof-of-concept studies for scientific break-
through. Application of the integrated innovation ap-
proach was highlighted as particularly beneficial for
education and professional development. One partici-
pant described the potential for growth afforded by this
funding: “by awarding this grant, GCC is truly challen-
ging us to go beyond our skills and acquire the right
knowledge and (or) collaborators to fit the integrated
innovation model”. Another participant described how
the funding could inform work in other contexts: “if
funded, my project could really be a blueprint for how
community-based HIV education is performed in dis-
placed and marginalized populations…there are 26
million people living in tents around the world that
could benefit from this project”.
Narratives also underscored the potential of lessons
learned to build theory: “not only are we testing out our
individual approaches to specific problems, but the suc-
cess or failure of our projects is really testing out the
theory of integrated innovation. That will be a huge
addition to global health research”. Another participant
reinforced the importance of learning not only from suc-
cess but also from failures: “you don’t need to report only
the successful discoveries; you need to also report thefailures, as you learn more from the failure than from
the success”. The commitment and persistence to find a
solution was articulated: “the recognition that combating
childhood cancer in the developing world is as important
as in the developed world is central to my vision—I am
not going to give up”.
Promotion of interdisciplinary collaboration
One unique benefit of being involved with GCC is the
opportunity for interdisciplinary collaboration intrinsic
to the Integrated Innovation™ approach: “You have this
mixture of social, business and scientific innovators; so
try to put them together, to collaborate and get things
done together. This is a very challenging and important
thing to do for the future”. This notion was reinforced by
another participant: “the cool thing about us connecting
is that we are out of the silos of our fields of expertise;
this is really getting transdisciplinary”. The 2012 Grand
Challenge meeting was described as enhancing under-
standing of business, social and health issues: “the mixer
with the Gates Foundation gave us exposure to per-
spectives beyond just Grand Challenges Canada”. The
general feeling of partnership was described as some-
thing worth fostering: “Grand Challenges Canada should
keep people in a collaborative spirit; they should focus
on this”.
Figure 1 Benefits and recommendations for engagement of new investigators in grand challenges research.
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tentially building partnerships: “you put a face to the
people; you start talking to them and seeing things
more clearly. You get the feeling that they are real
partners”. This has long-term implications for partner-
ships to engage in addressing global health issues:
“maybe in 2020 Grand Challenges Canada will have
built a network of collaborators between Canadian sci-
entists and scientists in the developed countries to solve
the problems of the developing world and to facilitate
communication and collaboration”. The field of Eco-
health (the study of how changes in ecosystems affect
human health), is a prime example of how interdiscip-
linary partnerships can address complex problems re-
lated to health by harnessing the collaborative power of
multidisciplinary stakeholders: from farmers and com-
munity members to healthcare workers, researchers and
government.
The importance of developing a community of scholars
was also highlighted:
We need a community of scholars and a community
of inquiry; a space where anybody who had been a
grand challenges star, or rising star, is part of a
larger family, a larger community of innovativethinkers. Maybe GCC could have a website or a
blog, or a meeting for people who are in the same
city, just so that we can be in touch to keep that
community active. That is what I really liked about
this meeting: we just met each other but it already
felt like a community.
Building a community of grand challenges recipients
was articulated as a valuable endeavor: “these people
have got a lot of potential so keeping them in the loop or
maybe trying to make a Phase 1 community [could be
valuable]”. This community of scholars was described as
important for both strengthening society as well as fos-
tering integrated innovation: “the strength of every soci-
ety, of every institution, is their people. So it depends on
how much you care for your people. If you get that pool
of people moving forward then you are going to be big, if
you are not able to integrate that, you are not going to
get integrated collaboration”.
Challenges and opportunities
Challenges and opportunities for Grand Challenges Canada
to move forward included a focus on capacity building,
ongoing mentorship for new investigators, and potential
for future commercialization.
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Participants discussed the need for support beyond fi-
nancial GCC contribution: “the social investment of
Grand Challenges Canada [is important]. It is not just
their money that we need. For the really impactful inno-
vations we need their time and human resources”. Com-
mitment to building capacity in new investigators was
perceived as critical to long-term success: “If you are
investing time and money in people that you know have
talent, try and help them move forward. Don’t just as-
sume 1 in 10 will be successful, but actively support them
to increase the ratio to, maybe, 5 in 10 successful stories”.
Capacity building was suggested regarding application of
the Integrated Innovation™ approach:
I really like the idea of integrating the scientific, social
and business aspects in the development of my idea,
but at the same time I find it hard because I am not
trained in all three. I don’t know how often people can
manage the three aspects…We need to integrate more
collaboration in our projects, get training and
integrate capacity-building. To genuinely develop our
ideas as integrated innovations, we will need the
support to do that.
Scaling up projects and commercialization was identi-
fied as another area for capacity building: “How big the
challenge is for us to try to develop integrated innova-
tions given our backgrounds and the type of projects we
are working on! Left alone we will have to do miracles to
get to the commercialization phase”. The authors felt
that the GCC grantee-oriented sessions at the meeting
(e.g. workshops covering the power of story telling, net-
working, grant writing, scale-up planning) were benefi-
cial. Other suggestions for capacity building specifically
address integrated innovation and case studies: “if I had a
dream vision for Grand Challenges for 2020 it’s actually
an online course for all the Phase 1 grantees, a lot of infor-
mation on social innovation, on technological innovation,
on business innovation and successful case studies of how
people got funding from Phase 1 to Phase 2”. Indeed, the
authors note that GCC is growing in this area, providing
resources for grantees and the public on their website
(http://www.grandchallenges.ca/resources/).
Mentorship
GCC ‘Rising Stars in Global Health’ awards were origin-
ally designed to attract Canadian scientists within ten
years of completing a PhD or terminal degree (e.g. M.D.)
to validate proof-of-concept proposals that addressed
any challenge in global health. These new investigators
were required to have a co-investigator in a low-and-
middle-income country (LMIC), also within ten years of
completing their degree. In a following Phase II application(also called Transition to Scale), these new investigators
have the opportunity to apply Integrated Innovation™ to
their validated proof-of-concept and scale-up their ap-
proach. Currently, the ‘Rising Stars in Global Health’
awards have evolved into ‘Stars in Global Health’ awards
now open to new investigators from LMICs, and to Can-
adian investigators at any level of experience and expertise.
This latter change to the eligibility requirements appears to
place new investigators at a disadvantage, as they must
compete for Phase II funding against some investigators
with presumably greater laboratory capacity, expertise, net-
works and connections, removing what was perceived as a
great opportunity for new investigators to launch their car-
eer and develop and test innovative theories and methods.
“This could significantly reduce the chance for new investi-
gators to benefit from the vital Phase I and II opportunities
to build research programs”.
Mentorship was discussed as key to navigating career
development, the implementation of Integrated Innovation™
and Phase II scale-up funding applications. Multidis-
ciplinary approaches to mentorship were recommended
that included: “trans-disciplinary or multi-disciplinary
mentorship, mentorship from people from the Gates
Foundation. Like people who got Phase II and then turned
back and mentored Phase I people, or people in Phase
III can mentor people in Phase II”. Technological ap-
proaches and virtual resources were suggested as an ap-
proach to international mentorship: “Linking [grantees] to
mentors, maybe at the Gates Foundation, maybe in differ-
ent countries with previous Phase II winners, or a virtual
resource that could guide [new investigators]. In seven
years, it could be a large enough group to significantly assist
future generations [of investigators]”.
Dialogue also focused on the challenges to providing
mentorship across such a wide array of research pro-
jects: “Our projects are so individual, and therefore genu-
inely difficult [to advise on the transition to Phase II]”.
The need to invest time in mentorship, beyond the con-
text of a meeting, was also highlighted: “Individual pro-
jects are diverse in nature and thus it is difficult to
support each one individually at a meeting like this”.
Potential for future commercialization
Integrated Innovation™ promotes a business approach to
health projects, in addition to social and scientific com-
ponents. In theory this approach allows key stakeholders
to create partnerships and work towards the resolution
of a common problem such a health-related issue. This
approach has been successfully implemented in develop-
ing countries. However, in the current global neoliberal
economy, this approach is often challenging to nearly
impossible when the target population of the innovation
does not represent a viable market, such as patients suf-
fering neglected diseases or marginalized people living in
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markets is a major contributor for diseases being under-
researched despite huge medical needs. In addition,
many funded projects, including the ones of the authors,
have limited or no patent protection and a low-to-null
return on financial investment. A participant gave a con-
crete example: “We will try to set up a women’s coopera-
tive on site but it will be very hard…I mean, I have to try
to create a sustainable business with and for people who
make four dollars a month”. In fact, the GCC Phase I
funding strategy could be correlated with a “survival of
the fittest” approach where a large number of awards are
given expecting fewer would progress. Closer interaction
and follow up would increase the success ratio. For
the Phase II application rounds, GCC is committed to
provide 50% matching funding, forcing innovators to
establish alliances and partnerships in view of future
commercialization. New—as well as more established
investigators—are required to seek private sources for
this 50% matching funding and are not eligible for
federal funding as GCC is partially funded by the
Canadian government. Soliciting private funding is an
approach that many researchers in academic settings
are ill-equipped or trained to do; additionally these in-
vestigators often have to navigate goals of internal
university fundraising initiatives.
Thus, without new, innovative funding mechanisms in
place and implicit GCC support to form those alliances,
and alternatives to fund projects serving marginalized
populations in low-income countries with few viable
markets, many of the Phase I GCC-funded ideas have
very little chance to reach commercialization despite
achieving proof-of-concept. This impedes contributions
to both scientific knowledge and global health promo-
tion. This concept was further highlighted: “This is not
just a question of capacity building. Political authorities
and GCC officers would need to facilitate this process by
creating new frameworks, for example, new incentives for
large companies to invest in global health, or by creating
global health foundations”. Social returns on investments
are, however, a tangible outcome for all GCC projects,
which may appeal to NGOs or to the so-called “impact
investors”, if properly addressed.
In addition, several GCC Phase I projects tackle proof-
of-concept studies at the basic science/molecular level.
Based on the history of pharmaceutical/biomedicine in-
dustry [13], it is unrealistic to assume that these types
of projects would reach a good position for commer-
cialization in the Phase II time-frame. An approach to
support this type of projects would be to award, in an
individual case-by-case basis and after peer-review,
Phase Ib grants with clearly established checkpoints in
the project development. This strategy, which is already
implemented by the BMGF, would help to overcome thelarge time lag between the proof-of-concept and the scal-
ing and commercialization stage.
Conclusions and recommendations
In this article we highlight experiences of GCC funding
recipients in undertaking research following the principle
of Integrated Innovation™, and their recommendations
for future GCC initiatives to maximize its impact in solv-
ing grand challenges in global health. In particular we
focus on the benefits and challenges of engaging in Inte-
grated Innovation™. This includes the potential to realize
the aims of the grand challenges approach while building
theory and strong evidence of its applicability and utility
in addressing global health issues. This approach can
inform scientific and technological breakthroughs that
address health issues across diverse contexts. Fostering
interdisciplinary, international collaborations and a com-
munity of scholars dedicated to a global health Integrated
Innovation™ approach was identified as a major benefit to
the growth and development of new investigators. How-
ever, a business focus seriously limits the potential for
global health innovations to reach the most marginalized
populations in low-income countries who may not
present a viable market. If the Integrated Innovation™ focus
on financial returns on investments overshadows social
and health returns this can reproduce the global health re-
search inequities that neglect diseases of poverty. The
widely debated gap in health research, where 10% of global
health funding targets diseases that impact 90% of the
population, spurred a health equity research agenda
[14-16]. Innovation for grand challenges in global health
should also interrogate how research approaches can chal-
lenge health inequities both within and between countries.
Specific recommendations for GCC include:
Enhanced Support for New Investigators:
1. Maintain and support the ‘Rising Stars’ award
program, whereby a proportion of Phase I and II
grants are designated for new investigators. This is
an invaluable opportunity to provide new scientists
with a platform to test a novel concept and to nurture
future generations of global health researchers. This
approach is used by other federal funding bodies (e.g.
Social Sciences and Humanities Research Council of
Canada) that allocates a proportion of Insight
Development Grants to new investigators.
2. Integrate a formal mentorship component to their
programs, linking new and senior global health
researchers, recognizing that the support of new
investigators involves more than just financial support.
This could take many formats, including meetings in
different regions, online platforms, webinars, examples
of successful grant applications, etc.
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3. Build a Grand Challenges community of scholars for
recipients of Phase I/II grants. This could foster
collaborations and networking, development of new
integrated innovations, and could take many forms,
including a website, blog, or meetings for scientists
local, national or internationally.
Support Commercialization and Scale-Up:
4. Develop a strong commercialization support
program where grant recipients are linked with
potential funders (e.g. NGOs, drug companies,
foundations, private investors) either directly or by
creating a widely distributed database of funded
projects to potential funders. GCC staff members
could individually work with grantees to assist them
to secure matching funding. For some projects,
offering an intermediate ‘Phase Ib’ program could
assist investigators in overcoming the large gap
between the proof-of-concept and the scale-up/
commercialization stage.
5. Value social returns on investment as equivalent to
financial returns on investment when working on
innovative health projects with marginalized
populations in low-income countries.
Building capacity in Integrated Innovation™ and the
skills to successfully scale-up the innovations that emerge,
in combination with interdisciplinary and international
mentorship, will support new investigators in further de-
veloping innovative approaches to solve grand challenges
in global health. GCC could play a pivotal role at promot-
ing new political frameworks, incentive measures and col-
lective conscious in the business and general community
to foster commercialization of innovations addressing the
needs of developing communities. Conceptualizing returns
on investments as social—not only financial—may be key
to promoting global health equity.Abbreviations
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